Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Response Genetics Inc
RGDXQCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
www.responsegenetics.com
ISIN
US76123U1051
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
PINK
Capitalization
11 639 USD
Yield for 12 month
0.00 %
1Y
3Y
5Y
10Y
15Y
RGDXQ
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California. Address: 1640 Marengo Street, Los Angeles, CA, United States, 90033
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.8 USDP/E ratio
–Dividend Yield
–Current Year
+18 040 000 USD
Last Year
+16 720 327 USD
Current Quarter
+3 790 604 USD
Last Quarter
+4 079 167 USD
Current Year
+3 942 000 USD
Last Year
+6 708 902 USD
Current Quarter
+1 475 955 USD
Last Quarter
+1 634 574 USD
Key Figures RGDXQ
1 year
3 years
5 years
10 years
EBITDA
-12 837 935 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-67.88 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
1.8 USD
Revenue TTM
16 615 997 USD
Book Value
-0.13 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-2.7 %
Dividend Yield
–
Gross Profit TTM
6 228 748 USD
Earnings per share
-0.39 USD
Diluted Eps TTM
-0.39 USD
Most Recent Quarter
I 2015
Quarterly Earnings Growth YOY
–
Profit Margin
-85.54 %
Dividend Analytics RGDXQ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RGDXQ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation RGDXQ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.512
Price Sales TTM
0.0007
Enterprise Value EBITDA
-0.477
Price Book MRQ
0.0002
Financials RGDXQ
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RGDXQ
For 52 weeks
0.0001 USD
0.0001 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
111 008
200 Day MA
0.0001 USD
Short Ratio
0.31
Shares Short
78 103
Short Percent
0.31 %
BeatStart